Tesamorelin Peptide Vial
Tesamorelin peptide vial is used to reduce extra abdominal fat in people who use specific HIV medicines and suffer from lipodystrophy (changes in how their fat is distributed). Some peptides reduce fat in the legs and arms and increase fat in the stomach and upper back.
This peptide stimulates the body to produce more growth hormones. It’s a synthetic GHRH analogue administered subcutaneously that significantly affects lipid and glucose metabolism. Tesamorelin’s potency in activating and binding GHRH receptors is comparable to the body’s natural GHRH. Moreover, it doesn’t hurt other pituitary hormones.
How Tesamorelin Works
Tesamorelin stimulates GHRH receptors. This leads to the release and synthesis of growth hormone, which works on different cells of the body. One of these cells is the hepatocytes that stimulate IGF-1 production. IGF-1 controls many of the effects of GH, including glucose uptake, lipolysis, and growth, as well as inhibiting programmed cell death.
This peptide vial effectively reduces visceral adiposity in individuals with lipodystrophy linked to antiretroviral therapy for HIV infection. It is also being assessed as therapy for obesity, insulin resistance, and non-alcoholic fatty liver disease (NAFLD).
Clinical trials proved time and again that Tesamorelin considerably lessens abdominal fat with few side effects compared to HGH itself. However, abdominal fat may return after the user stops taking this peptide.
Tesamorelin has been shown in clinical studies to improve executive function and, to a lesser extent, short-term verbal memory. In addition, the cognitive performance of healthy individuals increased, whereas the projected functional deterioration of those with mild cognitive impairment was slowed.
The studies identified the abilities that benefit from growth hormone-releasing factor treatment—abilities that are hampered by natural aging and the onset of Alzheimer’s disease.
Benefits of Tesamorelin
- Increase the natural production of human growth hormone
- Reduces triglycerides
- Increases IGF-1 without modifying glucose parameters
- Reduces VAT or Visceral Adipose Tissue
- Improves cognition in people over 60 years old
- Reduces cIMT or Carotid Intima-Media Size
References:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103937/
https://pubmed.ncbi.nlm.nih.gov/22869065/
Check out the Tesamorelin Sermorelin Peptide Stack here.
ALL PRODUCT INFORMATION AND ARTICLES ON THIS SITE ARE FOR EDUCATIONAL PURPOSES ONLY
DISCLAIMER: All products sold by PharmaGrade.Store are for research and laboratory use only. These products are not designed for use or consumption by humans or animals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such. By purchasing from our Website the buyer accepts and acknowledges the risks involved with handling of these products. All articles and product information provided on this Website are for informational and educational purposes only. Handling and use of these products should be restricted to suitably qualified professionals.